By Rachel Fixsen2021-05-14T13:53:00+01:00
Danish statutory pensions giant ATP announced it is investing in unlisted medical technology firm MedTrace, participating in a DKK180m (€24m) equity injection into the company alongside institutional investors Swisscanto Invest, BankInvest and others.
The firm, which has developed an automated technology that makes radioactive water available for diagnostic heart imaging in hospitals, said the new capital would be used to develop its cancer diagnostics work, among other things.
Claus Berner Møller, deputy director of Danish equities at ATP, said: “We hope, long term, to be able to pave the way for an IPO for MedTrace in Denmark.”